Utility of polygenic risk scores in UK cancer screening: a modelling analysis.

MLA

Huntley, Catherine, et al. “Utility of Polygenic Risk Scores in UK Cancer Screening: A Modelling Analysis.” The Lancet. Oncology, vol. 24, no. 6, June 2023, pp. 658–68. EBSCOhost, https://doi.org/10.1016/S1470-2045(23)00156-0.

APA

Huntley, C., Torr, B., Sud, A., Rowlands, C. F., Way, R., Snape, K., Hanson, H., Swanton, C., Broggio, J., Lucassen, A., McCartney, M., Houlston, R. S., Hingorani, A. D., Jones, M. E., & Turnbull, C. (2023). Utility of polygenic risk scores in UK cancer screening: a modelling analysis. The Lancet. Oncology, 24(6), 658–668. https://doi.org/10.1016/S1470-2045(23)00156-0

Chicago

Huntley, Catherine, Bethany Torr, Amit Sud, Charlie F Rowlands, Rosalind Way, Katie Snape, Helen Hanson, et al. 2023. “Utility of Polygenic Risk Scores in UK Cancer Screening: A Modelling Analysis.” The Lancet. Oncology 24 (6): 658–68. doi:10.1016/S1470-2045(23)00156-0.